tsla

ImmunoGen Stock Pullback Could Be a Buying Opportunity

IMGN stock is trading near a historically bullish trendline

Managing Editor
Apr 13, 2018 at 2:42 PM
facebook X logo linkedin


ImmunoGen, Inc. (NASDAQ:IMGN) is struggling today, down 2.3% to trade at $10.24. The biotech stock raced to a two-year high of $13.41 on March 26, but promptly pulled back in the past two weeks. If history is any guide, though, it could be time to bet on ImmunoGen's next leg higher.

Specifically, the shares have pulled back within one standard deviation of their ascending 80-day moving average. According to Schaeffer's Senior Quantitative Analyst Rocky White, after the previous four times IMGN stock pulled back to this moving average after spending a significant amount of time above it, it averaged a whopping 21-day gain of 21.81%, and was higher three-quarters of the time. A move of similar magnitude this time around would put the stock back near multi-year highs.

Pullbacks IMGN

A short squeeze could provide more tailwinds for the equity. Short interest fell by nearly 19% in the most recent reporting period, but the 11.05 million shares sold short represent 12% of the IMGN's total available float.

Although IMGN has added 59% already in 2018, analysts have been hesitant to come aboard. Of the 10 brokerages covering the security, four still rate it a "hold" or "strong sell." A resumed climb higher in the next few weeks may prompt analysts to re-think their bearish stance.

Despite the biotech stock's recent uptrend, the security remains plagued by pessimism in the options pits, although volume has been light on an absolute basis. The equity's Schaeffer's put/call open interest ratio (SOIR) of 3.23 ranks in the 94th percentile of its annual range, suggesting near-term traders have rarely been more put-biased in the past year. An unwinding of pessimism in the options pits could add fuel to the stock's fire.

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.